Megestrol AcetateHormone Therapy (Oncology) Indication: MegetTM is indicated for the treatment of:• Breast Cancer• Endometrial Cancer Dosage & Administration: Breast Cancer: 160 mg/day taken once daily. At least two months of continuous treatment is considered an adequate period for determining the efficacy of Meget™.Anorexia, cachexia or significant weight loss in patients with cancer: Usual adult dose: […]